Event agenda

Welcome & opening Remarks – From ATMP Ambition to Execution

Welcome and doors open time: 8:30 – 18:30.

Where Can Belgium Win? From Broad Ambition to Strategic Choices

This panel explores where Belgium should focus its investments and capabilities over the next 3 to 5 years to move from broad ATMP ambitions to a targeted, globally competitive strategy.

From Discovery to First Patient: How Can We Move Faster? Part 1

This two-part session will explore how Belgium can shorten the path from scientific discovery to the first patient by addressing both translational bottlenecks and emerging acceleration tools.

Coffee break

From Discovery to First Patient: How Can We Move Faster? Part 2

This two-part session will explore how Belgium can shorten the path from scientific discovery to the first patient by addressing both translational bottlenecks and emerging acceleration tools.

The New ATMP Manufacturing Reality: From Capacity to Capability

This panel explores how ATMP manufacturing is shifting from expanding raw capacity to optimizing capability, efficiency, and competitiveness through automation, smart infrastructure, and CDMO collaboration.

Lunch

Patient Testimony & Panel — From Innovation to Patient Access: Is Belgium Ready to Deliver? OR ATMP Access in Belgium: From Fragmented Pathways to a Patient-Ready System

Starting with a patient testimony, this panel evaluates Belgium's healthcare delivery infrastructure—including hospital readiness, logistics, and care coordination—to bridge the gap between ATMP innovation and timely patient access.

Funding the ATMP Journey: Biotech Entrepreneurs Share Their Lessons

Biotech entrepreneurs share candid accounts of securing private and public funding, discussing the realities of investor negotiations, post-funding execution, and preparing for future financing rounds.

Advanced Therapies, Strategic Autonomy & Defence dual-use technologies, biomanufacturing resilience, preparedness, supply chains…

Coffee break

From Projects to Portfolio: What ATMP-PIT Teaches Us About Accelerating Advanced Therapies

This session reflects on the legacy of the ATMP-PIT initiative, showcasing its key outputs and portfolio model while leveraging its assets and network to shape the future of Belgium's ATMP 2.0 strategy.

Closing Session

Official closure of ATMP-PIT and launch of the 2027–2030 Action Agenda.

Closing drink